WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
Hundreds of German police subdue 'hooligans' in training exercise for Euro 2024Crew members injured in crash on set of Eddie Murphy movie 'The Pickup'Remains believed to be missing woman, daughter found at West Virginia home on same day suspect diedActivists interrupt Chinese ambassador's Harvard speech — Radio Free AsiaTen of the world's best airports for food and drinks, according to expertsJunta attacks in Myanmar’s Bago region kill 8, displace 6,000 — Radio Free AsiaCrew members injured in crash on set of Eddie Murphy movie 'The Pickup'Man sentenced to 6 years in prison for attacking police with pole at CapitolTen of the world's best airports for food and drinks, according to expertsGoogle fires more workers who protested its deal with Israel